These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


689 related items for PubMed ID: 16377386

  • 1. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
    Sjöberg B, Anderstam B, Suliman M, Alvestrand A.
    Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
    [Abstract] [Full Text] [Related]

  • 2. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V, Kes P, Zeljko R, Kusec V.
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [Abstract] [Full Text] [Related]

  • 3. Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy.
    Suliman ME, Stenvinkel P, Qureshi AR, Bárány P, Heimburger O, Anderstam B, Alvestrand A, Lindholm B.
    Am J Kidney Dis; 2004 Sep; 44(3):455-65. PubMed ID: 15332218
    [Abstract] [Full Text] [Related]

  • 4. Cardiovascular risk assessment and homocysteine and leptin levels in peritoneal dialysis and hemodialysis patients.
    Bekpinar S, Unlüçerçi Y, Genç S, Türkmen A.
    Adv Perit Dial; 2005 Sep; 21():80-4. PubMed ID: 16686291
    [Abstract] [Full Text] [Related]

  • 5. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V, Kes P, Reiner Z.
    Acta Med Croatica; 2006 Sep; 60(1):21-6. PubMed ID: 16802568
    [Abstract] [Full Text] [Related]

  • 6. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
    Kárpáti I, Balla J, Szóke G, Bereczky Z, Páll D, Ben T, Toma K, Katona E, Mohácsi A, Paragh G, Varga Z, Kakuk G, Muszbek L.
    Orv Hetil; 2002 Jul 07; 143(27):1635-40. PubMed ID: 12180000
    [Abstract] [Full Text] [Related]

  • 7. Drug-induced pertubation of the aminothiol redox-status in patients with epilepsy: improvement by B-vitamins.
    Apeland T, Frøyland ES, Kristensen O, Strandjord RE, Mansoor MA.
    Epilepsy Res; 2008 Nov 07; 82(1):1-6. PubMed ID: 18644700
    [Abstract] [Full Text] [Related]

  • 8. Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.
    Ventura P, Panini R, Emiliani S, Salvioli G.
    Exp Clin Endocrinol Diabetes; 2004 Jan 07; 112(1):44-51. PubMed ID: 14758571
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
    Helal I, Smaoui W, Hamida FB, Ouniss M, Aderrahim E, Hedri H, Elyounsi F, Maiz HB, Abdallah TB, Kheder A.
    Saudi J Kidney Dis Transpl; 2010 Jan 07; 21(1):59-62. PubMed ID: 20061694
    [Abstract] [Full Text] [Related]

  • 10. Hyperhomocysteinemia in children on renal replacement therapy.
    Feinstein S, Sela BA, Drukker A, Becker-Cohen R, Raveh D, Gavendo S, Frishberg Y.
    Pediatr Nephrol; 2002 Jul 07; 17(7):515-9. PubMed ID: 12172765
    [Abstract] [Full Text] [Related]

  • 11. Homocysteinemia correlates with plasma thiol redox status in patients with end-stage renal disease.
    Palleschi S, De Angelis S, Rossi B, Diana L, Papa V, Severini G, Splendiani G.
    Nephron Clin Pract; 2008 Jul 07; 108(2):c106-12. PubMed ID: 18212512
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
    Azadibakhsh N, Hosseini RS, Atabak S, Nateghiyan N, Golestan B, Rad AH.
    Saudi J Kidney Dis Transpl; 2009 Sep 07; 20(5):779-88. PubMed ID: 19736473
    [Abstract] [Full Text] [Related]

  • 13. The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels.
    Borazan A, Aydemir S, Sert M, Yilmaz A.
    Mediators Inflamm; 2004 Dec 07; 13(5-6):361-4. PubMed ID: 15770053
    [Abstract] [Full Text] [Related]

  • 14. Homocysteine and its determinants in nondialyzed chronic kidney disease patients.
    Nerbass FB, Draibe SA, Feiten SF, Chiarello PG, Vannucchi H, Cuppari L.
    J Am Diet Assoc; 2006 Feb 07; 106(2):267-70. PubMed ID: 16442876
    [Abstract] [Full Text] [Related]

  • 15. What is the meaning of homocysteine in patients on dialysis?
    Silva de Almeida CC, Guerra DC, Vannucchi MT, Geleilete TJ, Vannucchi H, Chiarello PG.
    J Ren Nutr; 2011 Sep 07; 21(5):394-400. PubMed ID: 21439851
    [Abstract] [Full Text] [Related]

  • 16. Relationships between homocysteine and related amino acids in chronic hemodialysis patients.
    McDonald SP, Whiting MJ, Tallis GA, Barbara JA.
    Clin Nephrol; 2001 Jun 07; 55(6):465-70. PubMed ID: 11434358
    [Abstract] [Full Text] [Related]

  • 17. Relationship between hyperhomocysteinemia and atherosclerosis in chronic hemodialysis patients.
    Taruangsri P, Ong-Ajyooth L, Ong-Ajyooth S, Chaiyasoot W, Leowattana W, Sritippayawan S, Vareesangthip K, Chanchairujira T, Vasuvattakul S, Shayakul C, Vanichakarn S.
    J Med Assoc Thai; 2005 Oct 07; 88(10):1373-81. PubMed ID: 16519382
    [Abstract] [Full Text] [Related]

  • 18. Hyperhomocysteinemia as a possible role for atherosclerosis in CAPD patients.
    Kim SS, Hirose S, Tamura H, Nagasawa R, Tokushima H, Mitarai T, Isoda K.
    Adv Perit Dial; 1994 Oct 07; 10():282-5. PubMed ID: 7999846
    [Abstract] [Full Text] [Related]

  • 19. [Effect of folic acid supplementation on total homocysteine levels in hemodialysis patients].
    Armada E, Pérez Melón C, Otero A, Gayoso P, Rodríguez M, Esteban Morcillo J.
    Nefrologia; 2001 Oct 07; 21(2):167-73. PubMed ID: 11464650
    [Abstract] [Full Text] [Related]

  • 20. Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy.
    Suliman ME, Stenvinkel P, Heimbürger O, Bàràny P, Lindholm B, Bergström J.
    Am J Kidney Dis; 2002 Sep 07; 40(3):480-8. PubMed ID: 12200798
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 35.